enGene Holdings appoints Astley-Sparke and Heffernan to board committees

enGene Therapeutics Inc.

Philip Astley-Sparke appointed to Audit Committee and Nominating & Corporate Governance Committee.
Michael Heffernan appointed to Audit Committee and Compensation Committee.
Committee assignments effective October 2, 2025.

item 5.02

Source: SEC EDGAR

accession 0001193125-25-228331

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.